ArticleClinical and experimental nephrology2013
Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell-mediated immune function after renal transplantation.
Hao Zhou et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it